T-regulatory cells increase expression of ABCG2 and CD140P by K562 erythroleukemic cells in vitro
- Authors: Ostapchuk Y.O1, Tleulieva R.T1, Kan S.A1, Abdolla N.1
-
Affiliations:
- M.A. Aitkhozhin's Institute of Molecular Biology and Biochemistry
- Issue: Vol 14, No 3 (2019)
- Pages: 44-44
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/122140
- DOI: https://doi.org/10.23868/gc122140
- ID: 122140
Cite item
Open Access
Access granted
Abstract
Full Text
About the authors
Y. O Ostapchuk
M.A. Aitkhozhin's Institute of Molecular Biology and Biochemistry
Email: katyostapchuk@gmail.com
Laboratory of Almaty Kazakhstan
R. T Tleulieva
M.A. Aitkhozhin's Institute of Molecular Biology and BiochemistryLaboratory of Almaty Kazakhstan
S. A Kan
M.A. Aitkhozhin's Institute of Molecular Biology and BiochemistryLaboratory of Almaty Kazakhstan
N. Abdolla
M.A. Aitkhozhin's Institute of Molecular Biology and BiochemistryLaboratory of Almaty Kazakhstan
References
- Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nature Rev. Immunol. 2006; 6(4): 295-307.
- Ladoire S., Arnould L., Apetoh L. et al. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells. Clin. Cancer Res. 2008; 14: 2413-20.
Supplementary files
